Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Part A The primary study objective is to assess the efficacy of repeated s.c. injections at different doses of BIM 23A760 on patient’s overall satisfaction in terms of symptom relief (diarrhoea and/or flushes) in patients with carcinoid syndrome after 24 weeks of treatment. Part B The primary objective is to assess the long term safety of weekly injections of BIM 23A760 in patients with carcinoid syndrome.
Critère d'inclusion
- Carcinoid Syndrome